Quintela Fandiño, Miguel Angel miguel.quintela@uam.es
Actividades
- Artículos 52
- Libros 0
- Capítulos de libro 0
- Congresos 1
- Documentos de trabajo 0
- Informes técnicos 1
- Proyectos de investigación 0
- Tesis dirigidas 1
- Patentes o licencias de software 0
Phase II trial of vinorelbine tartrate in patients with treatment-naive metastatic melanoma
- Jimeno, A
- Hitt, R
- Quintela-Fandino, M
- Cortes-Funes, H;
Anti-Cancer Drugs (p. 53-57) - 1/1/2005
10.1097/00001813-200501000-00007 Ver en origen
- ISSN 14735741
Phase I clinical trial of nintedanib plus paclitaxel in early HER-2-negative breast cancer (CNIO-BR-01-2010/GEICAM-2010-10 study)
- Quintela-Fandino, M.
- Urruticoechea, A.
- Guerra, J.
- Gil, M.
- Gonzalez-Martin, A.
- Marquez, R.
- Hernandez-Agudo, E.
- Rodriguez-Martin, C.
- Gil-Martin, M.
- Bratos, R.
- Escudero, M. J.
- Vlassak, S.
- Hilberg, F.
- Colomer, R.;
British Journal Of Cancer (p. 1060-1064) - 1/1/2014
10.1038/bjc.2014.397 Ver en origen
- ISSN 00070920
Phase I Combination of Sorafenib and Erlotinib Therapy in Solid Tumors: Safety, Pharmacokinetic, and Pharmacodynamic Evaluation from an Expansion Cohort
- Quintela-Fandino, Miguel
- Le Tourneau, Christophe
- Duran, Ignacio
- Chen, Eric X.
- Wang, Lisa
- Tsao, Ming
- Bandarchi-Chamkhaleh, Bizhan
- Pham, Nhu-Ann
- Do, Trevor
- MacLean, Martha
- Nayyar, Rakesh
- Tusche, Michael W.
- Metser, Ur
- Wright, John J.
- Mak, Tak W.
- Siu, Lillian L.;
Molecular Cancer Therapeutics (p. 751-760) - 1/3/2010
10.1158/1535-7163.mct-09-0868 Ver en origen
- ISSN 15357163
Personalising and targeting antiangiogenic resistance: a complex and multifactorial approach
- Bueno, Maria J.
- Mouron, Silvana
- Quintela-Fandino, Miguel;
British Journal Of Cancer (p. 1119-1125) - 25/4/2017
10.1038/bjc.2017.69 Ver en origen
- ISSN 00070920
Normoxic or hypoxic adaptation in response to antiangiogenic therapy: Clinical implications
- Quintela-Fandino, M.;
Mol Cell Oncol - 2/9/2016
10.1080/23723556.2016.1217368 Ver en origen
- ISSN 23723556
Nintedanib plus letrozole in early breast cancer: A phase 0/I pharmacodynamic, pharmacokinetic, and safety clinical trial of combined FGFR1 and aromatase inhibition
- Quintela-Fandino M
- Apala J
- Malon D
- Mouron S
- Hornedo J
- Gonzalez-Cortijo L
- Colomer R
- Guerra J
Breast Cancer Research - 24/5/2019
10.1186/s13058-019-1152-x Ver en origen
- ISSN 14655411
Monitoring vascular normalization induced by antiangiogenic treatment with F-18-fluoromisonidazole-PET
- Hernández Agudo, Elena
- Mondejar, Tamara
- Soto Montenegro, Mª Luisa
- Megías, Diego
- Mourón, Silvana
- Sánchez, Jesús
- Hidalgo, Manuel
- López Casas, Pedro Pablo
- Mulero, Francisca
- Desco Menendez, Manuel
- Quintela Fandino, Miguel
Molecular Oncology (p. 704-718) - 1/5/2016
10.1016/j.molonc.2015.12.011 Ver en origen
- ISSN 1878-0261
Mitochondrial Inhibition: a Treatment Strategy in Cancer?
- Bueno, Maria J.
- Ruiz-Sepulveda, Jose L.
- Quintela-Fandino, Miguel;
Current Oncology Reports - 1/4/2021
10.1007/s11912-021-01033-x Ver en origen
- ISSN 15233790
MEK inhibition enhances the response to tyrosine kinase inhibitors in acute myeloid leukemia
- Luz Morales, Maria
- Arenas, Alicia
- Ortiz-Ruiz, Alejandra
- Leivas, Alejandra
- Rapado, Inmaculada
- Rodriguez-Garcia, Alba
- Castro, Nerea
- Zagorac, Ivana
- Quintela-Fandino, Miguel
- Gomez-Lopez, Gonzalo
- Gallardo, Miguel
- Ayala, Rosa
- Linares, Maria
- Martinez-Lopez, Joaquin;
Scientific Reports - 9/12/2019
10.1038/s41598-019-54901-9 Ver en origen
- ISSN 20452322
Irinotecan (CPT-11)-based chemotherapy as induction treatment for advanced colorectal cancer
- Quintela-Fandino M
- Gravalos C
- Gonzalez E
- García-Velasco A
- Cortés-Funes H
Anti-Cancer Drugs (p. 31-38) - 1/1/2005
10.1097/00001813-200501000-00004 Ver en origen
- ISSN 14735741
Este/a investigador/a no tiene libros.
Este/a investigador/a no tiene capítulos de libro.
Phase I clinical trial of neoadjuvant BIBF1120 plus weekly paclitaxel (P) in early HER-2 negative breast cancer. CNIO-BR-01-2010 GEICAM 2010-10 study
- Quintela-Fandino, M.
- Urruticoechea, A.
- Guerra, J.
- Gil, M.
- Gonzalez-Martin, A.
- Marquez, R.
- Hernandez-Agudo, E.
- Rodriguez-Martin, C.
- Gil, M.
- Bratos, R.
- Escudero, M. J.
- Colomer, R.;
Cancer Research - 15/12/2013
10.1158/0008-5472.sabcs13-pd5-8 Ver en origen
- ISSN 00085472
Este/a investigador/a no tiene documentos de trabajo.
A Phase I Study Investigating AZD8186, a Potent and Selective Inhibitor of PI3K?/?, in Patients with Advanced Solid Tumors
- Choudhury AD, Higano CS, de Bono JS, Cook N, Rathkopf DE, Wisinski KB, Martin-Liberal J, Linch M, Heath EI, Baird RD, García-Carbacho J, Quintela-Fandino M, Barry ST, de Bruin EC, Colebrook S, Hawkins G, Klinowska T, Maroj B, Moorthy G, Mortimer PG, Moschetta M, Nikolaou M, Sainsbury L, Shapiro GI, Siu LL, Hansen AR
Clinical Cancer Research (p. 2257-2269) - 1/1/2022
10.1158/1078-0432.ccr-21-3087 Ver en origen
- ISSN 15573265
Este/a investigador/a no tiene proyectos de investigación.
Este/a investigador/a no tiene patentes o licencias de software.
Perfiles de investigador/a
-
ORCID
-
Scopus Author ID
-
Dialnet id